Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cronos Group Inc (CRON) vs Quantum Computing Inc (QUBT) Price & Performance

Cronos Group IncTrade
Quantum Computing IncTrade

Price performance (Past 24H)

Key statistics

Cronos Group Inc vs Quantum Computing Inc — how do they compare? Cronos Group Inc trades at $3.22 (market cap $1.18B), while Quantum Computing Inc trades at $7.41 (market cap $1.69B). The key difference: Quantum Computing Inc is the larger of the two by market cap, and Cronos Group Inc is trading nearer its 52-week high, Quantum Computing Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Quantum Computing Inc for 25 Days on average.

CRONQUBT
Market Cap
$1.18B$1.69B
Volume
968,0377,991,522
Sector
HealthTechnology
52-Week High
$3.55$21.78
52-Week Low
$2.30$6.31
Typical Hold Time
22 Days25 Days
Enterprise Value
$387.62M$753.24M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cronos Group Inc

CRON trades at $3.24, down 1.37% today amid a bearish technical signal. Recent quarterly earnings show beats in Q1 and Q2 2026, with revenue growth from $118M in 2024 to $147M in 2025. The company reported a net loss of $9.45M in 2025 but projects a profit of $70M for 2026. Analyst sentiment is mixed with a 20% buy rating. News highlights focus on international expansion and a recent Investor Day outlining growth strategies.

Outlook is cautiously optimistic given projected profitability in 2026 and strong cash reserves, but risks include sustained negative cash flow and competitive pressures. The stock's valuation metrics like P/E of 16.95 and P/S of 6.84 suggest moderate pricing relative to peers, though high EV/EBITDA of 43 indicates premium expectations.

Quantum Computing Inc

QUBT trades at $7.39, down 3.02% today, amid a bearish technical signal from moving averages but bullish oscillators. The company reported Q2 2026 revenue of $5.6 million (Zacks Investment Research, 2026-09-08) but remains unprofitable with a net income margin of -152.45%. Recent news highlights the launch of Dirac-3S, scaling to 10,000 variables, with first shipments expected in Q4 2026 (PRNewsWire, 2026-10-01).

Analyst consensus is bullish with a $17.33 price target, but the stock faces significant risks from persistent losses, high cash burn, and competitive pressures. Investment appeal hinges on successful commercialization of quantum technology, though profitability remains distant. The company's $42.5 million backlog and liquidity provide some cushion against execution risks.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CRON

No sentiment data available yet.

QUBT
100% Buy0% Sell
Avg holding period · 25 Days

Top news

Latest headlines on both assets

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON →

About Quantum Computing Inc

Quantum Computing Inc. is a company focused on providing accessible quantum computing and quantum-enhanced software solutions for complex problems. The company's technology is designed to run on both classical and quantum hardware, enabling businesses to explore the power of quantum computing today for applications in finance, drug discovery, and logistics. QUBT offers a platform that makes quantum algorithms and software available through the cloud, aiming to democratize access to this advanced computing paradigm.

Read more on QUBT →